156 related articles for article (PubMed ID: 28460621)
1. 3D-QSAR, Virtual Screening, Docking and Design of Dual PI3K/mTOR Inhibitors with Enhanced Antiproliferative Activity.
Oluić J; Nikolic K; Vucicevic J; Gagic Z; Filipic S; Agbaba D
Comb Chem High Throughput Screen; 2017 Aug; 20(4):292-303. PubMed ID: 28460621
[TBL] [Abstract][Full Text] [Related]
2. PI3Kδ and mTOR dual inhibitors: Design, synthesis and anticancer evaluation of 3-substituted aminomethylquinoline analogues.
Yevale D; Teraiya N; Lalwani T; Dalasaniya M; Kapadiya K; Ameta RK; Sangani CB; Duan YT
Bioorg Chem; 2024 Jun; 147():107323. PubMed ID: 38583254
[TBL] [Abstract][Full Text] [Related]
3. Field-based 3D-QSAR for tyrosine protein kinase JAK-2 inhibitors.
Andole S; Thumma G; Alavala RR; Gangarapu K
J Biomol Struct Dyn; 2024 Jul; 42(10):5321-5333. PubMed ID: 37409931
[TBL] [Abstract][Full Text] [Related]
4. Pharmacophore-based virtual screening, 3D QSAR, Docking, ADMET, and MD simulation studies: An in silico perspective for the identification of new potential HDAC3 inhibitors.
Lanka G; Begum D; Banerjee S; Adhikari N; P Y; Ghosh B
Comput Biol Med; 2023 Nov; 166():107481. PubMed ID: 37741229
[TBL] [Abstract][Full Text] [Related]
5. In silico discovery of potent and selective Janus kinase 3 (JAK3) inhibitors through 3D-QSAR, covalent docking, ADMET analysis, molecular dynamics simulations, and binding free energy of pyrazolopyrimidine derivatives.
Faris A; Hadni H; Ibrahim IM; Elhallaoui M
J Biomol Struct Dyn; 2024 Jun; 42(9):4817-4833. PubMed ID: 37338041
[TBL] [Abstract][Full Text] [Related]
6. QSAR Study, Molecular Docking and Molecular Dynamic Simulation of Aurora Kinase Inhibitors Derived from Imidazo[4,5-
Tian YY; Tong JB; Liu Y; Tian Y
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675594
[TBL] [Abstract][Full Text] [Related]
7. In silico analysis of marine natural product for protein arginine methyltransferase 5(PRMT5) inhibitors based on pharmacophore and molecular docking.
Luo L; Tan H; Liao Y
J Biomol Struct Dyn; 2023; 41(22):13180-13197. PubMed ID: 36856049
[TBL] [Abstract][Full Text] [Related]
8. Evolutionary chemical binding similarity approach integrated with 3D-QSAR method for effective virtual screening.
Durai P; Ko YJ; Pan CH; Park K
BMC Bioinformatics; 2020 Jul; 21(1):309. PubMed ID: 32664863
[TBL] [Abstract][Full Text] [Related]
9. Molecular modeling, quantum polarized ligand docking and structure-based 3D-QSAR analysis of the imidazole series as dual AT(1) and ET(A) receptor antagonists.
Singh KD; Muthusamy K
Acta Pharmacol Sin; 2013 Dec; 34(12):1592-606. PubMed ID: 24304920
[TBL] [Abstract][Full Text] [Related]
10. Virtual docking screening and quantitative structure-activity relationship studies to explore AKT and PI3K inhibitors acting on mTOR in cancers by theoretical biology and medical modeling.
Kandoussi I; Abbou H; Haddoumi GE; Mansouri M; Belyamani L; Ibrahimi A
Contemp Oncol (Pozn); 2023; 27(3):155-162. PubMed ID: 38239868
[TBL] [Abstract][Full Text] [Related]
11. Optimization of virtual screening against phosphoinositide 3-kinase delta: Integration of common feature pharmacophore and multicomplex-based molecular docking.
Zhu J; Meng H; Li X; Jia L; Xu L; Cai Y; Chen Y; Jin J; Yu L
Comput Biol Chem; 2024 Apr; 109():108011. PubMed ID: 38198965
[TBL] [Abstract][Full Text] [Related]
12. A Combination of Pharmacophore Generation, Ligand-based Virtual Screening, Atom-based 3D-QSAR, and Molecular Docking Studies on Febuxostat-based Amides Analogues as Anti-inflammatory Agents.
Chitre T; Bhatambrekar A; Hirode P; Thorat S; Hajare SG; Garud D; Jagdale S; Asgaonkar K
Curr Drug Discov Technol; 2024 Mar; ():. PubMed ID: 38485685
[TBL] [Abstract][Full Text] [Related]
13. Multistage
Gupta S; Saha M; Singh R; Ahmed SB; Asati V
J Biomol Struct Dyn; 2024 Jan; ():1-18. PubMed ID: 38287494
[TBL] [Abstract][Full Text] [Related]
14. Structure-based ensemble-QSAR model: a novel approach to the study of the EGFR tyrosine kinase and its inhibitors.
Sun XQ; Chen L; Li YZ; Li WH; Liu GX; Tu YQ; Tang Y
Acta Pharmacol Sin; 2014 Feb; 35(2):301-10. PubMed ID: 24335842
[TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis and Molecular Docking Studies of Pyrazoline Derivatives as PI3K Inhibitors.
Kumar R; Kumar A; Kumar A; Singh AK; Kumar P
Comb Chem High Throughput Screen; 2024; 27(2):256-272. PubMed ID: 37143279
[TBL] [Abstract][Full Text] [Related]
16. '3D-QSAR-based, pharmacophore modelling, virtual screening, and molecular docking studies for identification of hypoxia-inducible factor-1 inhibitor with potential bioactivity.
Yadav PK; Singh S; Singh AK
Comput Biol Med; 2023 Nov; 166():107557. PubMed ID: 37812986
[TBL] [Abstract][Full Text] [Related]
17. Chemical and Structural Strategies to Selectively Target mTOR Kinase.
Borsari C; De Pascale M; Wymann MP
ChemMedChem; 2021 Sep; 16(18):2744-2759. PubMed ID: 34114360
[TBL] [Abstract][Full Text] [Related]
18. Fragment-based discovery of new potential DNMT1 inhibitors integrating multiple pharmacophore modeling, 3D-QSAR, virtual screening, molecular docking, ADME, and molecular dynamics simulation approaches.
Lanka G; Banerjee S; Adhikari N; Ghosh B
Mol Divers; 2024 Apr; ():. PubMed ID: 38637479
[TBL] [Abstract][Full Text] [Related]
19.
Chen Y; Tian Y; Gao Y; Wu F; Luo X; Ju X; Liu G
Front Chem; 2020; 8():164. PubMed ID: 32266208
[TBL] [Abstract][Full Text] [Related]
20. Virtual screening and structure-activity relationship study of novel BTK inhibitors in Traditional Chinese Medicine for the treatment of rheumatoid arthritis.
Sun L; Wang Z; Yang Z; Liu X; Dong H
J Biomol Struct Dyn; 2023; 41(24):15219-15233. PubMed ID: 36914235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
